DoubleLine&#x27s Jeff Gundlach warns that shares are as &#x27overvalued&#x27 as early 2022

DoubleLine&#x27s Jeff Gundlach warns that shares are as &#x27overvalued&#x27 as early 2022


Essential Details

  • DoubleLine CEO Jeffrey Gundlach warned Tuesday that stocks are buying and selling at amounts that resemble the start of the previous bear industry.
  • The prior bull market for shares peaked about two a long time in the past, with the S&P 500 hitting a record superior on Jan. 3, 2022.



Supply

Switzerland’s tariff shock: The 39% U.S. hit no one saw coming
World

Switzerland’s tariff shock: The 39% U.S. hit no one saw coming

The duty would be a “devastating” blow to the export-reliant Swiss economy and businesses, analysts say. Source

Read More
U.S. added just 73,000 jobs in July and numbers for prior months were revised much lower
World

U.S. added just 73,000 jobs in July and numbers for prior months were revised much lower

An attendee holds an “Entry Level Jobs” flyer at a City Career Fair hiring event in Sacramento, California, on Feb. 27, 2025. David Paul Morris | Bloomberg | Getty Images Nonfarm payroll growth was slower than expected in July and the unemployment rate ticked higher, raising potential trouble signs for the U.S. labor market. Job […]

Read More
Trump’s drug price ultimatum sets pharma firms scrambling
World

Trump’s drug price ultimatum sets pharma firms scrambling

Key Points A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday. President Trump sent letters to 17 major firms outlining the steps they must take to cut costs. Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump’s amended tariffs. Pharmaceutical firms are scrambling to respond […]

Read More